Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices 94749 

1 Modernization of Compliance Program 

Guidance Documents, 88 FR 25000 (Apr. 25, 2023). 

2All CPGs issued to date are currently available 

on the Compliance Guidance page of our website 

at https://oig.hhs.gov/compliance/complianceguidance/ (last visited Nov. 15, 2024). 

3To join OIG’s listserv, visit https://

cloud.connect.hhs.gov/OIG/. 

the transmission of antibiotic-resistant 

bacterial infections; including 

stewardship programs; and coordination 

with respect to international efforts in 

order to inform and advance the United 

States capabilities to combat antibiotic 

resistance. 

The focus of the January 28–29, 2025, 

meeting is to provide input and 

information to the Combating 

Antibiotic-Resistant Bacteria (CARB) 

Federal Task Force as they develop the 

next five-year iteration of the CARB 

National Action Plan 2025–2030. The 

meeting will focus on innovative and 

emerging topics in antimicrobial 

resistance (AMR), as well as insights 

from international CARB counterparts. 

The topics presented at the public 

meeting include: an overview of other 

partner country CARB National Action 

Plans; methods to measure global 

awareness of AMR; the impact of AMR 

and food security; AMR as a national 

security threat; a reflection on the 

United Nations General Assembly 

Political Declaration by Federal 

agencies; the economics of AMR; 

innovations to combat AMR; among 

other topics. 

Members of the public are invited to 

provide comment, especially on the 

2025–2030 CARB National Action Plan, 

during an extended public comment 

session, in-person during the meeting by 

pre-registering online at https://

www.hhs.gov/paccarb; pre-registration 

is required for participation in this 

session. Additionally, companies or 

organizations working to combat 

antimicrobial resistance my share their 

innovation during the January meeting 

by pre-registering to speak during the 

meeting’s Innovation Spotlight. Preregistration online at https://

www.hhs.gov/paccarb is required for 

participation in this session, and limited 

spots are available. The meeting agenda 

will be posted on the PACCARB website 

at https://www.hhs.gov/paccarb when it 

has been finalized. All agenda items are 

tentative and subject to change. 

Instructions regarding attending the 

meeting virtually will be posted at least 

one week prior to the meeting at: 

https://www.hhs.gov/paccarb. For those 

unable to attend in person, but who 

wish to provide input into the next 

iteration of the CARB National Action 

Plan 2025–2030, may provide written 

public comments that can be emailed to 

CARB@hhs.gov by midnight January 21, 

2025. All public comments received via 

email prior to January 21, 2025, will be 

provided to the PACCARB and 

Interagency CARB Task Force members. 

Dated: November 18, 2024. 

Jomana F. Musmar, 

Designated Federal Officer, Presidential 

Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant 

Secretary for Health. 

[FR Doc. 2024–28075 Filed 11–27–24; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of Inspector General 

General Compliance Program 

Guidance; Industry Segment-Specific 

Compliance Program Guidance for 

Skilled Nursing Facilities and Nursing 

Facilities; Resources for Industry; 

Availability 

AGENCY: Office of Inspector General 

(OIG), Department of Health and Human 

Services (HHS). 

ACTION: Notice of availability. 

SUMMARY: OIG is announcing the 

availability of the following resources 

for industry: General Compliance 

Program Guidance (GCPG) and Industry 

Segment-Specific Compliance Program 

Guidance for Skilled Nursing Facilities 

and Nursing Facilities (Nursing Facility 

ICPG). 

ADDRESSES: You may submit written 

electronic comments on these resources 

at any time by emailing Compliance@

oig.hhs.gov. 

FOR FURTHER INFORMATION CONTACT: 

GCPG: Contact Amanda Copsey, (202) 

577–6982, or Laura Ellis, (202) 834– 

1665. 

Nursing Facility ICPG: Contact Laura 

Morgan, (240) 930–2425, or Felicia 

Heimer, (202) 770–7017. 

SUPPLEMENTARY INFORMATION: 

I. Background 

On April 24, 2023, OIG announced 1

its plans to improve and update existing 

OIG Compliance Program Guidance 

documents (CPGs) and to deliver new 

CPGs specific to segments of the health 

care industry and entities involved in 

the health care industry that have 

emerged in recent years. 

Our April 2023 announcement 

explained, in part, that: 

• OIG developed CPGs as voluntary, 

nonbinding guidance documents to 

encourage the development and use of 

internal controls to monitor adherence 

to applicable statutes, regulations, and 

program requirements. 

• OIG will no longer publish updated 

or new CPGs in the Federal Register. 

All current, updated, and new CPGs 

will be available on our website.2

• OIG has developed a new format for 

CPGs: 

Æ First, the GCPG pertains to all 

individuals and entities involved in the 

health care industry. 

Æ Second, industry segment-specific 

CPGs (ICPGs) pertain to different types 

of providers, suppliers, and other 

participants in health care industry 

subsectors or ancillary industry sectors 

relating to Federal health care programs. 

Please reference the April 2023 

announcement for additional details. 

II. Notice of Availability 

Through this Notice of Availability, 

OIG is announcing the availability of the 

following documents: 

• GCPG: This document was 

published on OIG’s website on 

November 6, 2023. OIG notified the 

public of the publication of the GCPG 

using our public listserv 3 and other 

communications platforms. The GCPG 

may be viewed and downloaded at 

https://oig.hhs.gov/compliance/generalcompliance-program-guidance/ and 

https://oig.hhs.gov/documents/ 

compliance-guidance/1135/HHS-OIGGCPG-2023.pdf. 

• Nursing Facility ICPG: This 

document was published on OIG’s 

website on November 20, 2024. OIG is 

notifying the public of the publication 

of the Nursing Facility ICPG using our 

public listserv and other 

communications platforms. The Nursing 

Facility ICPG may be viewed and 

downloaded at https://oig.hhs.gov/ 

compliance/nursing-facility-icpg and 

https://oig.hhs.gov/documents/ 

compliance/10038/nursing-facilityicpg.pdf. 

These resources are not one-size-fitsall, comprehensive, or all-inclusive of 

compliance and quality considerations 

or risks. They are not binding on any 

individual or entity. Of note, OIG uses 

the word ‘‘should’’ in the GCPG and 

Nursing Facility ICPG to present 

voluntary, nonbinding guidance. This 

means that the documents do not create 

any new obligations or standards for any 

individual or entity. 

OIG may update the GCPG and 

Nursing Facility ICPG periodically to 

address newly identified risk areas and 

compliance and quality measures, 

ensure timely and meaningful OIG 

resources, and respond to stakeholder 

feedback. In addition, OIG anticipates 


khammond on DSK9W7S144PROD with NOTICES
94750 Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices 

publishing additional ICPGs addressing 

other health care industry segments in 

the future. 

OIG welcomes written and specific 

feedback from the health care 

community and other stakeholders in 

connection with the GCPG and the 

Nursing Facility ICPG. Any such 

feedback can be submitted by email to 

Compliance@oig.hhs.gov. The receipt of 

any feedback does not obligate OIG to 

take action, including responding to the 

feedback, making the feedback public, 

or issuing or revising public guidance. 

III. Paperwork Reduction Act of 1995 

These resources contain no collection 

of information. Therefore, clearance by 

the Office of Management and Budget 

under the Paperwork Reduction Act of 

1995 is not required. 

Christi A. Grimm, 

Inspector General. 

[FR Doc. 2024–28019 Filed 11–27–24; 8:45 am] 

BILLING CODE 4152–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Interdisciplinary 

Molecular Sciences and Training 

Integrated Review Group, Center for 

Scientific Review Special Emphasis 

Panel, December 5, 2024, 10 a.m. to 

December 5, 2024, 4 p.m., National 

Institutes of Health, Rockledge II, 6701 

Rockledge Drive, Bethesda, MD 20892 

which was published in the Federal 

Register on November 08, 2024, 89 FR 

88789, Doc 2024–25937. 

This meeting is being amended to 

change the meeting start time from 

10:00 a.m. to 8:00 a.m. to accommodate 

an increase in applications being 

discussed. The meeting is closed to the 

public. 

Dated: November 22, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–28001 Filed 11–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; NIDDK High Risk 

Multi-Center Clinical Study Review Meeting. 

Date: January 22, 2025. 

Time: 10:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

NIDDK, Democracy II, Suite 7000A, 6707 

Democracy Boulevard, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Michele L. Barnard, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 7343, 6707 Democracy Boulevard, 

Bethesda, MD 20817, (301) 594–8898, 

barnardm@extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: November 22, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–28002 Filed 11–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request; Generic Clearance for the 

Collection of Qualitative Feedback on 

Agency Service Delivery (National 

Institute Allergy and Infectious 

Diseases) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995 to provide 

opportunity for public comment on 

proposed data collection projects, the 

National Institute of Allergy and 

Infectious Diseases (NIAID) will publish 

periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 60 days of the date of this 

publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Sarah Hijaz, Health Science 

Policy Analyst, Office of Strategic 

Planning, Initiative Development and 

Analysis, 5601 Fishers Lane, Rockville, 

Maryland 20892 or call non-toll-free 

number (301)761–7790 or Email your 

request, including your address to: 

sarah.hijaz@nih.gov. Formal requests for 

additional plans and instruments must 

be requested in writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: written 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimizes 

the burden of the collection of 

information on those who are to 

respond, including the use of 


khammond on DSK9W7S144PROD with NOTICES